Cargando…

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused

Detalles Bibliográficos
Autores principales:	Chaudhary, Sachin, Natt, Bhupinder, Bime, Christian, Knox, Kenneth S., Glassberg, Marilyn K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992361/ https://www.ncbi.nlm.nih.gov/pubmed/33777966 http://dx.doi.org/10.3389/fmed.2020.604640

Ejemplares similares

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020)

Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Seifirad, Soroush, et al.
Publicado: (2021)

Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas
por: Casanova, Nancy G., et al.
Publicado: (2020)

The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015)

Systemic Sclerosis Associated Interstitial Lung Disease: New Directions in Disease Management
por: Mirsaeidi, Mehdi, et al.
Publicado: (2019)

Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
por: Cottin, Vincent, et al.
Publicado: (2021)

FANCJ lets chromatin stay true
por: Leslie, Mitch
Publicado: (2013)

FANCJ lets chromatin stay true
por: Leslie, Mitch
Publicado: (2013)

Let’s talk numbers: a qualitative study of community-dwelling US adults to understand the role of numeracy in the management of heart failure
por: Sterling, Madeline R, et al.
Publicado: (2018)

Correction to: SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
por: Nikolich-Zugich, Janko, et al.
Publicado: (2020)

SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
por: Nikolich-Zugich, Janko, et al.
Publicado: (2020)

Antifibrotics in India
por: Dhar, Raja
Publicado: (2019)

Let It End With Us
por: Shannon, Kelly
Publicado: (2022)

Corrigendum: The functional trajectory in frail compared with non-frail critically ill patients during the hospital stay
por: Fuest, K. E., et al.
Publicado: (2023)

“Live and Let Die”: What We Learned From US Healthcare and What Seems to Be Valid in the COVID-19 Pandemic
por: Jüttemann, Andreas Gerd, et al.
Publicado: (2021)

Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion
por: Farhat, Ryan M., et al.
Publicado: (2020)

Early drainage reduces the length of hospital stay in patients with lung abscess
por: Chiang, Po-Chang, et al.
Publicado: (2023)

Strategies to DAMPen COVID-19-mediated lung and systemic inflammation and vascular injury
por: Bime, Christian, et al.
Publicado: (2021)

Let us do it ourselves()
por: Schor, Paulo
Publicado: (2014)

Let Us Be up and Doing
Publicado: (1907)

Let Us Reason Together
Publicado: (1893)

Let Us Have Peace
Publicado: (1887)

Miliary Tuberculosis in a Young Patient? Let's Not Forget the Lung Adenocarcinoma!
por: Zia, Zeeshan, et al.
Publicado: (2020)

Airway Management in the Critically Ill Patient
por: Natt, Bhupinder, et al.
Publicado: (2021)

Pharmacological basis of the antifibrotic effects of pirfenidone: Mechanistic insights from cardiac in-vitro and in-vivo models
por: Sartiani, Laura, et al.
Publicado: (2022)

Foxp3-Positive Regulatory T Cells Contribute to Antifibrotic Effects in Renal Fibrosis via an Interleukin-18 Receptor Signaling Pathway
por: Hirooka, Yasuaki, et al.
Publicado: (2020)

Case Report: Let Us Not Forget the Treatment That Some Patients Have Received—The Brief 50-Year History of a Kidney Transplant Survivor
por: Nordheim, Espen, et al.
Publicado: (2022)

SARS-CoV-2 Rapid Antigen Testing of Symptomatic and Asymptomatic Individuals on the University of Arizona Campus
por: Harris, David T., et al.
Publicado: (2021)

Antifibrotic in interstitial lung diseases: When, where, and how long?
por: Rai, Deependra K., et al.
Publicado: (2022)

The influence of immortal time bias in observational studies examining associations of antifibrotic therapy with survival in idiopathic pulmonary fibrosis: A simulation study
por: Zheng, Qiang, et al.
Publicado: (2023)

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
por: Bos, Saskia, et al.
Publicado: (2021)

Let’s focus on our Nursery school!
por: Staff Association
Publicado: (2016)

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis
por: Tzouvelekis, Argyrios, et al.
Publicado: (2018)

Let us march ahead with optimism
por: Faizuddin, Mohamed
Publicado: (2011)

Let Us Do Not Forget Durability
por: Somberg, John
Publicado: (2020)

Let Us Flatten the Infodemic Curve…
por: Geetha Dharmesh, Balsarkar
Publicado: (2021)

Come Now and Let Us Reason
por: Beecher, Thos. K.
Publicado: (1884)

Risk-Based Care: Let's Think Outside the Box
por: Chase, James Geoffrey, et al.
Publicado: (2021)

Frailty index, mortality, and length of stay in a geriatric short-stay unit in Guadeloupe
por: Vainqueur, Larissa, et al.
Publicado: (2022)

Deciphering the Antifibrotic Property of Metformin
por: Septembre-Malaterre, Axelle, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5831fgf7sgslb76flfbk2fpsnq